Properties and protective value of the secondary versus primary T helper type 1 response to airborne Mycobacterium tuberculosis infection in mice

被引:116
作者
Jung, YJ [1 ]
Ryan, L [1 ]
LaCourse, R [1 ]
North, RJ [1 ]
机构
[1] Trudeau Inst Inc, Saranac Lake, NY 12983 USA
关键词
D O I
10.1084/jem.20050265
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mice immunized against Mycobacterium tuberculosis (Mtb) infection by curing them of a primary lung infection were compared with naive mice in terms of the ability to generate a Th1 cell immune response and to control growth of an airborne Mtb challenge infection. Immunized mice generated and expressed Th1 cell immunity several days sooner than naive mice, as demonstrated by an earlier increase in the synthesis in the lungs of mRNA for Th1 cytokines and for inducible nitric oxide synthase, an indicator of macrophage activation. This Th1 cytokine/ mRNA synthesis was accompanied by an earlier accumulation of Mtb-specific Th1 cells in the lungs and the presence of CD4 T cells in lesions. An earlier generation of immunity was associated with an earlier inhibition of Mtb growth when infection was at a 1-log lower level. However, inhibition of Mtb growth in immunized, as well as in naive, mice was not followed by resolution of the infection, but by stabilization of the infection at a stationary level. The results indicate that there is no reason to believe that the secondary response to an Mtb infection is quantitatively or qualitatively superior to the primary response.
引用
收藏
页码:1915 / 1924
页数:10
相关论文
共 39 条
[1]  
Al Zahrani K, 2000, AM J RESP CRIT CARE, V162, P1419, DOI 10.1164/ajrccm.162.4.9912048
[2]   Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10 [J].
Arend, SM ;
Andersen, P ;
van Meijgaarden, KE ;
Skjot, RLV ;
Subronto, YW ;
van Dissel, JT ;
Ottenhoff, THM .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (05) :1850-1854
[3]  
Brandt L, 1996, J IMMUNOL, V157, P3527
[4]   Improving vaccines against tuberculosis [J].
Britton, WJ ;
Palendira, U .
IMMUNOLOGY AND CELL BIOLOGY, 2003, 81 (01) :34-45
[5]   Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease [J].
Caminero, JA ;
Pena, MJ ;
Campos-Herrero, MI ;
Rodríguez, JC ;
Afonso, O ;
Martin, C ;
Pavón, JM ;
Torres, MJ ;
Burgos, M ;
Cabrera, P ;
Small, PM ;
Enarson, DA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (03) :717-720
[6]   TUBERCULOSIS IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME - CLINICAL-FEATURES, RESPONSE TO THERAPY, AND SURVIVAL [J].
CHAISSON, RE ;
SCHECTER, GF ;
THEUER, CP ;
RUTHERFORD, GW ;
ECHENBERG, DF ;
HOPEWELL, PC .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987, 136 (03) :570-574
[7]   Mycobacterium tuberculosis-driven processes in gene-disrupted mice [J].
Cooper, AM ;
Saunders, BM ;
DSouza, CD ;
Frank, AA ;
Orme, IM .
BULLETIN DE L INSTITUT PASTEUR, 1997, 95 (02) :85-96
[8]   The growing burden of tuberculosis - Global trends and interactions with the HIV epidemic [J].
Corbett, EL ;
Watt, CJ ;
Walker, N ;
Maher, D ;
Williams, BG ;
Raviglione, MC ;
Dye, C .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (09) :1009-1021
[9]   Mapping of murine Th1 helper T-cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis [J].
D'Souza, S ;
Rosseels, V ;
Romano, A ;
Tanghe, A ;
Denis, O ;
Jurion, P ;
Castiglione, N ;
Vanonckelen, A ;
Palfliet, K ;
Huygen, K .
INFECTION AND IMMUNITY, 2003, 71 (01) :483-493